Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

ELIL vs TBXU: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

TBXU Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 3–0 Matrix Metrics)

TBXU Overall Winner 6-Pillar Tally: ELIL 0 – 0 TBXU (6 Tie) Matrix Metrics: ELIL 0 – 3 TBXU

As of Nov 20, 2026, Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) is the stronger overall head-to-head candidate over Direxion Daily LLY Bull 2X Shares (ELIL) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). ELIL carries a Unified Composite Score of 42.5/100 (HOLD) at $36.41 (N/M Forward P/E, N/A operating margin), whereas TBXU carries 48.6/100 (HOLD) at $44.26 (N/M Forward P/E, N/A operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ELIL vs TBXU
ELIL NASDAQ
Direxion Daily LLY Bull 2X Shares
Institutional Equity
$36.41
-0.44% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.63β · 70% Vol
Unified Composite Score
42.5 / 100 HOLD
Tech 38.0 Fund 33.0 Flow 50.0 Mom 11.1
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 48
RSI-14: 48.1 · SMA20: $38.63 · SMA50: $32.94
TBXU NYSE Arca Head-to-Head Winner
Direxion Daily Biotech Top 5 Bull 2X ETF
Institutional Equity
$44.26
-1.42% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.74β · 47% Vol
Unified Composite Score
48.6 / 100 HOLD
Tech 38.0 Fund 43.0 Flow 50.0 Mom 31.1
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 48
RSI-14: 48.3 · SMA20: $46.02 · SMA50: $41.74

6-Pillar Scorecard Institutional Category Breakdown (ELIL 0 – 0 TBXU)

Columns: Metric · ELIL · TBXU
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 56.2% (<1st %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ELIL (0) vs TBXU (3)
Institutional Metric ELIL TBXU Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
74% ($16–$44) 78% ($27–$49) Stronger Trend TBXU
Beta / 30D Volatility
Risk Regime
0.63β · 70% Vol 0.74β · 47% Vol Lower Realized Risk TBXU
Unified Institutional Score
Composite Signal
42.5 / 100 (HOLD) 48.6 / 100 (HOLD) Higher Composite TBXU
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon TBXU +1.46 pp
ELIL: +4.6% · TBXU: +6.06%
3M Horizon ELIL +10.57 pp
ELIL: +11.0% · TBXU: +0.43%
6M Horizon TBXU +8.26 pp
ELIL: +44.47% · TBXU: +52.73%
1Y Horizon TBXU +19.13 pp
ELIL: +18.6% · TBXU: +37.73%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ELIL vs TBXU. Trailing 12-month operating profitability (ELIL N/A vs TBXU N/A) and valuation multiples (ELIL N/M vs TBXU N/M Forward P/E) are benchmarked directly in Pillar 4 below.

ELIL ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
TBXU ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ELIL UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 56.2%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ELIL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
TBXU UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact TBXU Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ELIL Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
TBXU Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ ELIL vs TBXU Key Questions & Quantitative Answers

As of Nov 20, 2026, Direxion Daily Biotech Top 5 Bull 2X ETF (TBXU) is the stronger overall head-to-head candidate over Direxion Daily LLY Bull 2X Shares (ELIL) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). ELIL carries a Unified Composite Score of 42.5/100 (HOLD) at $36.41 (N/M Forward P/E, N/A operating margin), whereas TBXU carries 48.6/100 (HOLD) at $44.26 (N/M Forward P/E, N/A operating margin). Technically, ELIL sits in a Neutral phase (RSI 48.1, UNCLASSIFIED options structure) and TBXU sits in a Neutral phase (RSI 48.3, UNCLASSIFIED options structure).

ELIL and TBXU split Growth & Scale metrics: ELIL posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with TBXU at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, ELIL generates N/A in USD-normalized revenue versus N/A for TBXU. In operating R&D and SG&A reinvestment, ELIL deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for TBXU.

ELIL and TBXU trade at balanced relative valuation multiples. ELIL trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas TBXU trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ELIL (N/A ROE) versus TBXU (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, ELIL carries 56.2% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.63β · 70% Vol realized risk). By comparison, TBXU carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.74β · 47% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.